Cite
HARVARD Citation
Oshrine, B. et al. (n.d.). Mixed chimerism and graft loss in pediatric recipients of an alemtuzumab‐based reduced‐intensity conditioning regimen for non‐malignant disease. Pediatric blood & cancer. 61 (10), pp. 1852-1859. [Online].